Bellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers Symposium
Stock Information for Bellicum Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.